Lushan Peng
Overview
Explore the profile of Lushan Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng L, Peng X
Gland Surg
. 2024 Nov;
13(10):1830-1839.
PMID: 39544980
Background: Breast cancer is one of the most common malignant tumors, occurring in the mammary glands, which often metastasizes to bones, lungs, and liver. However, pituitary metastasis (PM) originating from...
2.
Liu Z, Zeinalzadeh Z, Huang T, Han Y, Peng L, Wang D, et al.
Heliyon
. 2024 Sep;
10(17):e37053.
PMID: 39296237
Endoplasmic reticulum stress (ERS) becomes a significant factor in inflammatory bowel disease (IBD), like Crohn's disease (CD) and ulcerative colitis (UC). Our research was aimed at identifying molecular markers to...
3.
Peng L, Peng X, Duan S, Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2024 May;
49(2):319-330.
PMID: 38755729
Hepatic lymphoepithelioma-like carcinoma (LELC) is an extremely rare malignant tumor characterized by undifferentiated malignant epithelial cells and significant lymphatic infiltration. Hepatic LELC mainly includes lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) and lymphoepithelioma-like...
4.
Wang X, Chen B, Zhang H, Peng L, Liu X, Zhang Q, et al.
Int J Surg
. 2024 Mar;
110(7):4083-4095.
PMID: 38546506
Background: The molecular features of fibroblasts and the role of fibrosis in neoadjuvant chemotherapy (NAC) response and breast cancer (BRCA) prognosis remain unclear. Therefore, this study aimed to investigate the...
5.
Jin H, Liao W, Yang S, Peng L, Xing W
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2024 Mar;
48(12):1920-1928.
PMID: 38448386
Objectives: Intravascular large B-cell lymphomas are a rare group of extranodal non-Hodgkin's lymphomas with no apparent specificity of symptoms and often a poor prognosis. This study aims to investigate the...
6.
Liu Z, Zeinalzadeh Z, Huang T, Han Y, Peng L, Wang D, et al.
Transl Oncol
. 2024 Feb;
42:101896.
PMID: 38324960
Esophageal cancer, known for its high incidence and low five-year survival rate, poses significant treatment challenges. A key aspect of this challenge is the close link between mitochondria and resistance...
7.
Jiang Z, Zhou J, Deng J, Li L, Wang R, Han Y, et al.
Cell Death Discov
. 2023 Jun;
9(1):193.
PMID: 37369681
Ferroptosis, a novel mode of cell death dependent on iron and reactive oxygen species, has been extensively explored during malignant tumors metastasis. Ferroptosis can interact with multiple components of the...
8.
Wang D, Han Y, Peng L, Huang T, He X, Wang J, et al.
Int J Biol Sci
. 2023 May;
19(7):2198-2219.
PMID: 37151887
N6-methyladenosine (m6A) is the most abundant RNA modification in eukaryotes, and it participates in the regulation of pathophysiological processes in various diseases, including malignant tumors, by regulating the expression and...
9.
Sun N, Khan U, Zeng L, Wu P, Xiong Q, Peng L, et al.
Front Surg
. 2023 Mar;
10:1108942.
PMID: 36911622
Background: Schwannomas are benign tumors originating from Schwann cells, frequently occurring in the spinal cord and peripheral nerves. Intraosseous schwannomas, a rare subset, account for approximately 0.2% of schwannomas. Intraosseous...
10.
Huang T, Peng L, Han Y, Wang D, He X, Wang J, et al.
Front Immunol
. 2022 Sep;
13:922301.
PMID: 36090974
Messenger RNA (mRNA) vaccines constitute an emerging therapeutic method with the advantages of high safety and efficiency as well as easy synthesis; thus, they have been widely used in various...